₹276.60
-9.30 (-3.25%)
As of 28 Aug 2026, Bafna Pharmaceuticals Ltd share price is ₹276.60. The stock opened at ₹276.60 and had closed at ₹285.90 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹95.00 and a high of ₹296.00. In terms of performance, Bafna Pharmaceuticals Ltd share price has increased by 147.41% over the past six months and has increased by 171.18% over the last year.
BAFNAPH Charts
Bafna Pharmaceuticals Ltd Overview
Market cap₹654 Crs
Volume3,496
Prev. Close₹285.90
Year range₹95.00 - ₹296.00
Total Value₹9,66,993.60
ISININE878I01022
About BAFNAPH
Bafna Pharmaceuticals is engaged in the business of manufacturing of finished pharmaceutical formulations.
Bafna Pharmaceuticals Ltd Historical Performance
1 Month Return11.17%
6 Month Return157.66%
3 Year Return164.49%
3 Month Return105.65%
1 Year Return179.39%
5 Year Return101.90%
Bafna Pharmaceuticals Ltd Fundamental Analysis
ROCE(TTM)10.63%
P/E Ratio (TTM)84.07
P/B Ratio6.81
Debt to Equity0.39
ROE11.54%
EPS (TTM)3.29
Dividend Yield0.00%
Book Value40.64
Profit Margin5.46%
Operating Margin3.70%
Bafna Pharmaceuticals Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 28.49 | 44.00 | 39.51 | 36.65 | 35.22 |
| EBITDA | 2.80 | 5.31 | 4.27 | 5.45 | 5.67 |
| Net Profit | 0.08 | 2.75 | 1.84 | 3.12 | 3.39 |
| EPS | 0.03 | 1.16 | 0.78 | 1.32 | 1.43 |
Bafna Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 67.67 |
| MACD | 7.56 |
| 20-Day SMA | 268.54 |
Bafna Pharmaceuticals Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Bafna Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Bafna Pharmaceuticals Ltd today is ₹276.60 on NSE and ₹276.60 on BSE.
- The 52-week high of Bafna Pharmaceuticals Ltd is ₹296.00, while the 52-week low is ₹95.00.
- The current market capitalisation of Bafna Pharmaceuticals Ltd is approximately ₹654 crore.
- The P/E (Price-to-Earnings) ratio of Bafna Pharmaceuticals Ltd is 84.07. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Bafna Pharmaceuticals Ltd is 6.81. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Bafna Pharmaceuticals Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Bafna Pharmaceuticals Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Bafna Pharmaceuticals Ltd has delivered a return of approximately 164.49%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Bafna Pharmaceuticals Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 75.00% promoters, 9.34% FIIs, 0.00% DIIs, and 11.97% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
